| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000017645 |
| Receipt No. | R000020443 |
| Official scientific title of the study | Efficacy of Fluticasone propionate / Formoterol fumarate hydrate on human bronchial mucocillially movement using bronchoscopic specimen |
| Date of disclosure of the study information | 2015/05/21 |
| Last modified on | 2016/05/22 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Efficacy of Fluticasone propionate / Formoterol fumarate hydrate on human bronchial mucocillially movement using bronchoscopic specimen | |
| Title of the study (Brief title) | Fluticasone / Formoterol on human bronchial mucocillially movement | |
| Region |
|
|
| Condition | ||
| Condition | Respiratory disease requiring bronchoscopy | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the effect of Fluticasone/fumarate on the improvement of mucociliary transport ability of human bronchial epithelium, by a high-speed shooting evaluation method using bronchoscopy specimens. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Activity of the movement of cilia of epithelial cells, ciliary movement frequency, and ciliary movement amplitude before and after Fluticasone/fumarate load |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Historical |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | administration of Fluticasone / Formoterol | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Respiratory disease requiring bronchoscopy and bronchial lavage clinically | |||
| Key exclusion criteria | serious major organ dysfunction | |||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Toshiyujki Sawa |
| Organization | Gifu Municipal Hospital |
| Division name | Cancer Center |
| Address | Kashima-cho, 7-1, Gifu City |
| TEL | 0081-58-251-1101 |
| sawatoshiyuki@yahoo.co.jp | |
| Public contact | |
| Name of contact person | Toshiyujki Sawa |
| Organization | Gifu Municipal Hospital |
| Division name | Cancer Center |
| Address | Kashima-cho, 7-1, Gifu City |
| TEL | 0081-58-251-1101 |
| Homepage URL | |
| sawatoshiyuki@yahoo.co.jp | |
| Sponsor | |
| Institute | Gifu Municipal Hospital |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Gifu Municipal Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Local Government |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 岐阜市民病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000020443 |